Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of sporadic somatotropinomas with high GIP receptor expression.

Pituitary - 1 Dec 2022

Faria Olivia, Miranda Renan Lyra, de Azeredo Lima Carlos Henrique, Guterres Alexandro, Ventura Nina, Barbosa Monique Alvares, da Silva Camacho Aline Helen, Lamback Elisa Baranski, Andreiuolo Felipe, Chimelli Leila, Kasuki Leandro, Gadelha Mônica R

Abstract excerpt

PURPOSE: To analyze the expression of glucose-dependent insulinotropic polypeptide receptor (GIPR) in somatotropinomas specimens and compare clinical, biochemical, radiological, therapeutic, molecular, and pathological data among those who overexpressed (GIPR +) and those who did not overexpress (GIPR - ) GIPR. METHODS: Clinical, biochemical, radiological, molecular, and pathological data were collected. GNAS1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Real-Time Polymerase Chain Reaction

Source

Identifiers

PMID: 36066838
DOI: 10.1007/s11102-022-01272-6

Genes

GIPR
GIP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of sporadic somatotropinomas with high GIP receptor expression.PMID 36066838Read ↗

Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative SomatotropinomasSemantic proximity Read ↗

Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomaeSemantic proximity Read ↗

Whole-Genome Sequencing of Growth Hormone (GH)-Secreting Pituitary Adenomas.Semantic proximity Read ↗

Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas.Semantic proximity Read ↗

The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.Semantic proximity Read ↗

Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumorsSemantic proximity Read ↗

Transcriptomic classification of pituitary neuroendocrine tumors causing acromegalySemantic proximity Read ↗

miR ‐34a is upregulated in AIP ‐mutated somatotropinomas and promotes octreotide resistanceSemantic proximity Read ↗

Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing AcromegalySemantic proximity Read ↗

Somatotroph Tumors and the Epigenetic Status of the GNAS Locus.Semantic proximity Read ↗

Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma.Semantic proximity Read ↗

Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.